LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Gregor Thomas, Ph.D.: New Medical Director at curasan AG
People In The News

Gregor Thomas, Ph.D.: New Medical Director at curasan AG

August 10, 2016 1 min read Premium comments

Advertisement

Gregor Thomas, Ph.D.: New Medical Director at curasan AG
Gregor Thomas, Ph.D.

Gregor Thomas, Ph.D., who brings years of experience in the orthopedic, oral surgery and reconstructive dentistry specialties, has been appointed as new Medical Director at curasan AG. He replaces Dr. Wolf-Dietrich Hübner, who will retire at the end of this year.

Dr. Thomas will lead the medical affairs, clinical research, regulatory affairs and quality systems departments.

Dr. Thomas told OTW, “I studied medicine and dentistry and worked for some years as an assistant doctor in the department of Oro-Maxillo-Facial Surgery of the University Hospital in Würzburg. I did my Ph.D. in orthopedics, working on low grade infections of endoprosthetical implants. After about 15 years in my own practice, focused on surgery and functional diseases I started my first job in industry in R&D. My last projects were in bio glass development.

“We are very busy as the company has some new products and we are registering a very innovative product for bone regeneration on the American market. As the company is actually growing on different markets there is a huge effort for registration which requires new staff in the medical department. My first important goal of implementing a distributor for UK is just reached. Writing publications for magazines is another task, also nursing the contacts with our KOLs [key opinion leaders] and creating new contacts with universities. In a summary I can say that my daily business is pretty exciting and I am looking forward to the future with curasan.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy